Payers, Startups, Health Tech

Bright Health to grow footprint in 2022, adding 42 new markets

Bright Health will use proceeds from its IPO to fund the expansion, which will bring its total number of markets to 141 from 99. The company will also expand its product portfolio in states where it already operates.

health insurance

Insurance startup Bright Health has big plans for 2022.

On Tuesday, the Minneapolis-based company announced plans to expand its operations to 42 new markets next year across Texas, Georgia, Utah and Virginia. This will boost its total number of markets to 141 from 99.

The planned expansion will also grow Bright Health’s overall footprint to 17 states, up from 14, bringing it close to rival Oscar Health’s current operations spanning 19 states. But Oscar is planning to expand to three new states next year, bringing its total footprint to 22.

Not only will Bright Health expand to new markets, but it will also broaden its product portfolio in states where it already has a presence, including in Florida, California, Colorado and North Carolina. The company did not provide any details on its plans for product expansion, but it did note that Bright will be the first plan to be added to California’s state-based exchange, Covered California, in six years.

The insurtech company currently caters to over 663,000 consumers, offering individual and family health, Medicare Advantage and employer plans. It also offers several specialized plans, such as Chronic Condition Special Needs Plans, which exclusively serve those with severe chronic conditions.

Bright Health’s proprietary DocSquad technology supports its insurance products. DocSquad is a suite of consumer and care provider solutions, allowing users to search, compare and virtually connect to care delivery from a single app, the company said in response to an email inquiry from MedCity News.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

The news of the expansion comes soon after the company announced its initial public offering. Bright Health is aiming to raise about $1.3 billion through its IPO, offering 60 million shares of its common stock at between $20 and $23 per share. IPO proceeds will be used to fund the market expansion.

Another key priority for Bright Health in 2022 is to diversify its business, the company said. Its diversification efforts began earlier this year with the purchase of telehealth platform provider Zipnosis.

For the second quarter of 2021, Bright Health reported revenues of $1.1 billion, but it also recorded a net loss of $43 million, up from $21 million in Q1. This was the first financial statement the company released after its IPO filing.

The insurtech market is soaring, with companies raking in $4.8 billion in funding in Q2 2021, a 210% increase compared with the same period last year, according to a report by CB Insights.

Several other insurance startups have already announced market expansions in 2022, including Clover Health and Alignment Healthcare.

Photo: marchmeena29, Getty Images